• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study.1型和2型糖尿病患者的血清脂质管理:一项基于医院的队列研究。
Diabetol Int. 2018 Jul 28;10(1):67-76. doi: 10.1007/s13340-018-0365-z. eCollection 2019 Jan.
2
The relationship between body mass index, blood pressure, and atherosclerosis risk factors in type 1 and 2 diabetic patients from northwestern Algeria.北非阿尔及利亚西北部 1 型和 2 型糖尿病患者的体重指数、血压与动脉粥样硬化危险因素的关系。
Endocr Regul. 2022 Jul 13;56(3):190-200. doi: 10.2478/enr-2022-0020.
3
Vitamin D is negatively associated with triglyceride in overweight/obese patients with type 2 diabetes.在超重/肥胖的2型糖尿病患者中,维生素D与甘油三酯呈负相关。
Endocrine. 2022 May;76(2):304-311. doi: 10.1007/s12020-022-03009-8. Epub 2022 Mar 5.
4
Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels.区分 GCK-MODY 患者的脂质谱及其与 hsCRP 水平的相关性。
Front Endocrinol (Lausanne). 2022 Oct 26;13:1024431. doi: 10.3389/fendo.2022.1024431. eCollection 2022.
5
Overweight and obese youth with type 1 or type 2 diabetes share similar elevation in triglycerides during middle and late adolescence.患有1型或2型糖尿病的超重及肥胖青少年在青春期中后期甘油三酯水平均有相似程度的升高。
Obes Res Clin Pract. 2022 Mar-Apr;16(2):138-143. doi: 10.1016/j.orcp.2022.03.003. Epub 2022 Apr 13.
6
Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus.脂类组学特征及 1 型和 2 型糖尿病的性别特异性差异。
Cardiovasc Diabetol. 2024 Mar 29;23(1):109. doi: 10.1186/s12933-024-02202-5.
7
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes.部分临床缓解可降低成年 1 型糖尿病患者的基于脂质的心血管风险。
Front Endocrinol (Lausanne). 2021 Nov 17;12:705565. doi: 10.3389/fendo.2021.705565. eCollection 2021.
8
High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without / with intensive insulin therapy.1 型糖尿病和 2 型糖尿病患者及接受强化胰岛素治疗患者的高密度脂蛋白亚型。
Endocr J. 2012;59(7):561-9. doi: 10.1507/endocrj.ej11-0329. Epub 2012 May 16.
9
A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey).一项评估中东欧地区糖尿病二级护理情况的跨国、多中心、观察性横断面调查(DEPAC调查)。
Diabet Med. 2008 Oct;25(10):1195-203. doi: 10.1111/j.1464-5491.2008.02570.x.
10
Carbohydrate intake in relation to BMI, HbA1c and lipid profile in children and adolescents with type 1 diabetes.1型糖尿病儿童和青少年的碳水化合物摄入量与体重指数、糖化血红蛋白及血脂谱的关系
Clin Nutr. 2014 Feb;33(1):75-8. doi: 10.1016/j.clnu.2013.03.017. Epub 2013 Apr 6.

本文引用的文献

1
A large-scale observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 1 diabetes-JDCP study 2.一项调查日本糖尿病并发症现状及其预防情况的大规模观察性研究:1型糖尿病-JDCP研究2的研究大纲及基线数据
Diabetol Int. 2016 Jan 8;7(1):4-11. doi: 10.1007/s13340-015-0248-5. eCollection 2016 Mar.
2
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.日本动脉粥样硬化协会(JAS)2017年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.
3
9. Cardiovascular Disease and Risk Management: .9. 心血管疾病与风险管理: 。
Diabetes Care. 2018 Jan;41(Suppl 1):S86-S104. doi: 10.2337/dc18-S009.
4
Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?绝经和糖尿病对致动脉粥样硬化血脂谱的影响:分析脂蛋白亚组分以评估女性心血管风险是否值得?
Diabetol Metab Syndr. 2017 Apr 7;9:22. doi: 10.1186/s13098-017-0221-5. eCollection 2017.
5
Optimal Management Target for Non-High-Density Lipoprotein Cholesterol.非高密度脂蛋白胆固醇的最佳管理目标
J Atheroscler Thromb. 2016;23(4):399-401. doi: 10.5551/jat.ED036. Epub 2016 Feb 12.
6
Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: the Circulatory Risk in Communities Study (CIRCS).日本男性和女性的空腹及非空腹甘油三酯水平与缺血性心血管疾病风险:社区循环风险研究(CIRCS)
Atherosclerosis. 2014 Nov;237(1):361-8. doi: 10.1016/j.atherosclerosis.2014.08.028. Epub 2014 Sep 6.
7
Evaluation and treatment of older patients with hypercholesterolemia: a clinical review.高龄高胆固醇血症患者的评估和治疗:临床综述。
JAMA. 2014 Sep 17;312(11):1136-44. doi: 10.1001/jama.2014.10924.
8
Statin intolerance.他汀类药物不耐受。
Am J Cardiol. 2014 May 15;113(10):1765-71. doi: 10.1016/j.amjcard.2014.02.033. Epub 2014 Mar 2.
9
Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: the DERI Mortality Study.日本一项全国性基于人群的儿童起病 1 型糖尿病队列研究中 35 年随访期间的病因特异性死亡率趋势:DERI 死亡率研究。
Diabetologia. 2013 Oct;56(10):2171-5. doi: 10.1007/s00125-013-3001-2. Epub 2013 Aug 1.
10
Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.预测 2 型糖尿病的大血管和微血管并发症:日本糖尿病并发症研究/日本老年糖尿病干预试验风险引擎。
Diabetes Care. 2013 May;36(5):1193-9. doi: 10.2337/dc12-0958. Epub 2013 Feb 12.

1型和2型糖尿病患者的血清脂质管理:一项基于医院的队列研究。

Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study.

作者信息

Hasegawa Yukiko, Nakagami Tomoko, Oya Junko, Isago Chisato, Kurita Moritoshi, Tanaka Yuki, Ito Arata, Tsuzura Reika, Hirota Naoki, Miura Junnosuke, Uchigata Yasuko

机构信息

Diabetes Center, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku, Tokyo, 162-8666 Japan.

出版信息

Diabetol Int. 2018 Jul 28;10(1):67-76. doi: 10.1007/s13340-018-0365-z. eCollection 2019 Jan.

DOI:10.1007/s13340-018-0365-z
PMID:30800565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6357242/
Abstract

INTRODUCTION

Serum lipid management is important for patients with diabetes; however, it has not been examined in our specialized diabetes clinic.

AIMS

The aim of the study was to assess the percentage of patients who did not achieve management targets (MT) for low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C) and triglycerides (TG), and explore factors related to failure to achieve lipid MT in Japanese patients with type 1 (T1D) and type 2 diabetes (T2D).

METHODS

This cross-sectional study included 795 patients (35% men) with T1D and 4018 patients (60% men) with T2D attending our diabetes center. MTs for serum lipids were in accordance with the guidelines of the Japan Atherosclerosis Society. Logistic regression analysis was performed to identify factors related to failure to achieve MTs for serum lipids.

RESULTS

The percentages of men/women who did not achieve MT for LDL-C were 34.1/31.8% in T1D and 40.5/52.7% in T2D. The corresponding values for TG were 35.1/14.0% in T1D and 50.1/47.9% in T2D, and for HDL-C were 2.5/0% in T1D and 8.6/2.9% in T2D. Increase in body mass index (BMI) and glycated hemoglobin (HbA1c) were significantly and independently associated with failure to achieve lipid MT in patients with T1D and T2D for both sexes.

CONCLUSIONS

The percentages of our patients who did not achieve serum lipid MT were relatively high in T1D and T2D, and higher HbA1c and BMI were associated with failure to achieve serum lipid MTs. More attention should be paid to lipid management in patients with diabetes especially who have higher HbA1c and BMI in our facility.

摘要

引言

血清脂质管理对糖尿病患者很重要;然而,在我们的专科糖尿病诊所尚未对此进行过研究。

目的

本研究旨在评估未达到低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和甘油三酯(TG)管理目标(MT)的患者百分比,并探讨日本1型糖尿病(T1D)和2型糖尿病(T2D)患者未达到脂质MT的相关因素。

方法

这项横断面研究纳入了在我们糖尿病中心就诊的795例T1D患者(35%为男性)和4018例T2D患者(60%为男性)。血清脂质的MT符合日本动脉粥样硬化学会的指南。进行逻辑回归分析以确定与未达到血清脂质MT相关的因素。

结果

T1D中未达到LDL-C MT的男性/女性百分比分别为34.1%/31.8%,T2D中为40.5%/52.7%。T1D中TG的相应值为35.1%/14.0%,T2D中为50.1%/47.9%,HDL-C的相应值在T1D中为2.5%/0%,T2D中为8.6%/2.9%。体重指数(BMI)和糖化血红蛋白(HbA1c)的升高与T1D和T2D患者未达到脂质MT显著且独立相关。

结论

在T1D和T2D中,我们的患者未达到血清脂质MT的百分比相对较高,较高的HbA1c和BMI与未达到血清脂质MT相关。在我们的机构中,应更加关注糖尿病患者尤其是HbA1c和BMI较高患者的脂质管理。